Symbicort brought in worldwide sales of $2.7 ... has been given the nod for use by the NHS in England after an earlier rejection. Regulators have started reviews of GSK's depemokimab, aiming ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback